Marcus Corporation Reports Fourth Quarter and Full Year Fiscal 2025 Results
“Both of our divisions outperformed their industries in the fourth quarter, with
Fourth Quarter Fiscal 2025 Highlights
-
Total revenues for the fourth quarter of fiscal 2025 were
$193.5 million , a 2.8% increase from total revenues of$188.3 million for the fourth quarter of fiscal 2024. Revenues were favorably impacted by a shift in operating days due to the previously announced change in the Company’s fiscal calendar as described further below. -
Operating income was
$1.7 million for the fourth quarter of fiscal 2025, compared to operating loss of$2.2 million for the prior year quarter. Operating income for the fourth quarter of fiscal 2025 was negatively impacted by$5.2 million , or$0.12 per diluted common share net of tax, of noncash impairment charges. Operating loss for the fourth quarter of fiscal 2024 was negatively impacted by$6.4 million , or$0.15 per share net of tax, of noncash impairment charges. -
Net earnings was
$6.0 million for the fourth quarter of fiscal 2025, compared to net earnings of$1.0 million for the same period in fiscal 2024. Net earnings for the fourth quarter of fiscal 2025 was favorably impacted by$7.6 million , or$0.25 per diluted common share, of income tax benefit from a historic rehabilitation tax credit (net of valuation allowance) from theHilton Milwaukee renovation. Net earnings for the fourth quarter of fiscal 2024 was favorably impacted by$6.0 million , or$0.19 per diluted common share, of income tax benefit due to decreases in valuation allowances for deferred state income taxes. -
Net earnings per diluted common share was
$0.19 for the fourth quarter of fiscal 2025, compared to net earnings per diluted common share of$0.03 for the fourth quarter of fiscal 2024. -
Adjusted EBITDA was
$26.8 million for the fourth quarter of fiscal 2025, a 3.6% increase from Adjusted EBITDA of$25.9 million for the prior year quarter.
Full Year Fiscal 2025 Highlights
-
Total revenues for fiscal 2025 were
$758.5 million , a 3.1% increase from total revenues of$735.6 million for fiscal 2024. -
Operating income was
$17.1 million for fiscal 2025, a 5.5% increase from operating income of$16.2 million for fiscal 2024. Operating income for fiscal 2025 was negatively impacted by$5.2 million , or$0.12 per diluted common share net of tax, of noncash impairment charges. Operating income for fiscal 2024 was negatively impacted by$6.8 million , or$0.16 per share net of tax, of noncash impairment charges. -
Net earnings was
$12.7 million for fiscal 2025, compared to net loss of$7.8 million for fiscal 2024. Net earnings for fiscal 2025 was favorably impacted by$7.6 million , or$0.24 per diluted common share, of income tax benefit from a historic rehabilitation tax credit (net of valuation allowance) from theHilton Milwaukee renovation, and was favorably impacted by a$3.4 million , or$0.11 per share, gain from a property insurance settlement, net of tax. Net loss for fiscal 2024 was favorably impacted by$6.1 million , or$0.19 per diluted common share, of income tax benefit due to decreases in valuation allowances for deferred state income taxes, and was negatively impacted by$16.7 million , or$0.52 per diluted common share, of debt conversion expense and related tax impacts of convertible senior notes repurchases. -
Net earnings per diluted common share was
$0.41 for fiscal 2025, compared to net loss per diluted common share of$0.25 for fiscal 2024. -
Adjusted EBITDA was
$99.3 million for the full year fiscal 2025, a 3.1% decrease from Adjusted EBITDA of$102.4 million for fiscal 2024.
For the fourth quarter of fiscal 2025,
For the full year fiscal 2025,
“Marcus Theatres benefitted from a favorable mix of films in the fourth quarter, with blockbuster hits like Zootopia 2, Wicked: For Good, and Avatar: Fire and Ash and exciting originals like The Housemaid and Marty Supreme giving moviegoers of all ages and demographics a reason to enjoy incredible entertainment experiences at the movies,” said
Several films have contributed to early fiscal 2026 first quarter results, including the carry over impact of late 2025 releases including Avatar: Fire and Ash, Zootopia 2, The Housemaid,
During the fourth quarter of fiscal 2025, total revenues before cost reimbursements were
Revenue per available room, or RevPAR, increased 3.5% at comparable company-owned hotels during the fourth quarter of fiscal 2025 compared to the prior year period. As a result,
For the full year fiscal 2025,
“We are proud to deliver another year of record revenues and Adjusted EBITDA, made even more impressive considering the number of rooms out of service during the
Group booking pace for fiscal 2026 is running slightly ahead compared to the same period in fiscal 2025. Banquet and catering revenue for fiscal 2026 is running similarly ahead of the same time last year.
In
In
Looking ahead,
Return of Capital to Shareholders
During the fourth quarter of fiscal 2025, the Company repurchased 0.1 million shares of common stock for
Since resuming share repurchases in the third quarter of fiscal 2024, the Company has repurchased 1.8 million shares of common stock, or 5.7% of the shares outstanding, for
As of
Fiscal Year Change
Beginning in fiscal 2025, the Company’s fiscal year changed from a 52-53 week fiscal year ending on the last Thursday of each year to a fiscal year ending on
Conference Call and Webcast
A telephone replay of the conference call will be available through
Non-GAAP Financial Measure
Adjusted EBITDA has been presented in this press release as a supplemental measure of financial performance that is not required by, or presented in accordance with, GAAP. The company defines Adjusted EBITDA as net earnings (loss) attributable to
Adjusted EBITDA is a key measure used by management and the company’s board of directors to assess the company’s financial performance and enterprise value. The company believes that Adjusted EBITDA is a useful measure, as it eliminates certain expenses and gains that are not indicative of the company’s core operating performance and facilitates a comparison of the company’s core operating performance on a consistent basis from period to period. The company also uses Adjusted EBITDA as a basis to determine certain annual cash bonuses and long-term incentive awards, to supplement GAAP measures of performance to evaluate the effectiveness of its business strategies, to make budgeting decisions, and to compare its performance against that of other peer companies using similar measures. Adjusted EBITDA is also used by analysts, investors and other interested parties as a performance measure to evaluate industry competitors.
Adjusted EBITDA is a non-GAAP measure of the company’s financial performance and should not be considered as an alternative to net earnings (loss) as a measure of financial performance, or any other performance measure derived in accordance with GAAP and it should not be construed as an inference that the company’s future results will be unaffected by unusual or non-recurring items. Additionally, Adjusted EBITDA is not intended to be a measure of liquidity or free cash flow for management’s discretionary use. In addition, this non-GAAP measure excludes certain non-recurring and other charges and has its limitations as an analytical tool. You should not consider Adjusted EBITDA in isolation or as a substitute for analysis of the company’s results as reported under GAAP. In evaluating Adjusted EBITDA, you should be aware that in the future the company will incur expenses that are the same as or similar to some of the items eliminated in the adjustments made to determine Adjusted EBITDA, such as acquisition expenses, preopening expenses, accelerated depreciation, impairment charges and other adjustments. The company’s presentation of Adjusted EBITDA should not be construed to imply that the company’s future results will be unaffected by any such adjustments. Definitions and calculations of Adjusted EBITDA differ among companies in our industries, and therefore Adjusted EBITDA disclosed by the company may not be comparable to the measures disclosed by other companies.
About
Headquartered in
Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally be identified as such because the context of such statements include words such as we “believe,” “anticipate,” “expect” or words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which may cause results to differ materially from those expected, including, but not limited to, the following: (1) the adverse effects future pandemics or epidemics may have on our theatre and hotels and resorts businesses, results of operations, liquidity, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness; (2) the availability, in terms of both quantity and audience appeal, of motion pictures for our theatre division (including disruptions in the production of films due to events such as a strike by actors, writers or directors or future pandemics); (3) the effects of theatre industry dynamics such as the maintenance of a suitable window between the date such motion pictures are released in theatres and the date they are released to other distribution channels; (4) the effects of adverse economic conditions in our markets; (5) the effects of adverse economic conditions on our ability to obtain financing on reasonable and acceptable terms, if at all; (6) the effects on our occupancy and room rates caused by the relative industry supply of available rooms at comparable lodging facilities in our markets; (7) the effects of competitive conditions in our markets; (8) our ability to achieve expected benefits and performance from our strategic initiatives and acquisitions; (9) the effects of increasing depreciation expenses, reduced operating profits during major property renovations, impairment losses, and preopening and start-up costs due to the capital intensive nature of our business; (10) the effects of changes in the availability of and cost of labor and other supplies essential to the operation of our business; (11) the effects of tariffs that are implemented or merely threatened on our costs; (12) the effects of weather conditions, particularly during the winter in the Midwest and in our other markets; (13) our ability to identify properties to acquire, develop and/or manage and the continuing availability of funds for such development; (14) the adverse impact on business and consumer spending on travel, leisure and entertainment resulting from terrorist attacks in
|
|
|||||||||||||||
|
|
|||||||||||||||
|
Consolidated Statements of Operations |
|||||||||||||||
|
(Unaudited) |
|||||||||||||||
|
(in thousands, except per share data) |
|||||||||||||||
|
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Revenues: |
|
|
|
|
|
|
|
||||||||
|
Theatre admissions |
$ |
59,392 |
|
|
$ |
56,265 |
|
|
$ |
220,385 |
|
|
$ |
214,421 |
|
|
Rooms |
|
25,762 |
|
|
|
24,616 |
|
|
|
114,544 |
|
|
|
113,344 |
|
|
Theatre concessions |
|
51,001 |
|
|
|
50,759 |
|
|
|
197,856 |
|
|
|
191,989 |
|
|
Food and beverage |
|
21,153 |
|
|
|
20,384 |
|
|
|
84,410 |
|
|
|
78,102 |
|
|
Other revenues |
|
26,353 |
|
|
|
26,118 |
|
|
|
100,563 |
|
|
|
97,230 |
|
|
|
|
183,661 |
|
|
|
178,142 |
|
|
|
717,758 |
|
|
|
695,086 |
|
|
Cost reimbursements |
|
9,837 |
|
|
|
10,171 |
|
|
|
40,700 |
|
|
|
40,474 |
|
|
Total revenues |
|
193,498 |
|
|
|
188,313 |
|
|
|
758,458 |
|
|
|
735,560 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Costs and expenses: |
|
|
|
|
|
|
|
||||||||
|
Theatre operations |
|
61,511 |
|
|
|
59,909 |
|
|
|
234,680 |
|
|
|
225,472 |
|
|
Rooms |
|
10,530 |
|
|
|
10,550 |
|
|
|
43,624 |
|
|
|
43,425 |
|
|
Theatre concessions |
|
20,419 |
|
|
|
20,943 |
|
|
|
82,169 |
|
|
|
78,406 |
|
|
Food and beverage |
|
16,335 |
|
|
|
15,392 |
|
|
|
63,900 |
|
|
|
60,419 |
|
|
Advertising and marketing |
|
7,012 |
|
|
|
6,111 |
|
|
|
26,077 |
|
|
|
24,559 |
|
|
Administrative |
|
21,977 |
|
|
|
21,724 |
|
|
|
92,578 |
|
|
|
88,958 |
|
|
Depreciation and amortization |
|
17,915 |
|
|
|
17,970 |
|
|
|
70,191 |
|
|
|
67,958 |
|
|
Rent |
|
6,368 |
|
|
|
6,437 |
|
|
|
25,243 |
|
|
|
25,911 |
|
|
Property taxes |
|
3,597 |
|
|
|
2,655 |
|
|
|
16,222 |
|
|
|
14,716 |
|
|
Other operating expenses |
|
11,087 |
|
|
|
12,284 |
|
|
|
40,838 |
|
|
|
42,269 |
|
|
Impairment charges |
|
5,172 |
|
|
|
6,351 |
|
|
|
5,172 |
|
|
|
6,823 |
|
|
Reimbursed costs |
|
9,837 |
|
|
|
10,171 |
|
|
|
40,700 |
|
|
|
40,474 |
|
|
Total costs and expenses |
|
191,760 |
|
|
|
190,497 |
|
|
|
741,394 |
|
|
|
719,390 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Operating income (loss) |
|
1,738 |
|
|
|
(2,184 |
) |
|
|
17,064 |
|
|
|
16,170 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other income (expense): |
|
|
|
|
|
|
|
||||||||
|
Investment income |
|
414 |
|
|
|
557 |
|
|
|
878 |
|
|
|
2,231 |
|
|
Interest expense |
|
(2,903 |
) |
|
|
(2,812 |
) |
|
|
(11,472 |
) |
|
|
(10,972 |
) |
|
Other income (expense) |
|
(452 |
) |
|
|
(392 |
) |
|
|
2,848 |
|
|
|
(1,513 |
) |
|
Debt conversion expense |
|
— |
|
|
|
(203 |
) |
|
|
— |
|
|
|
(15,521 |
) |
|
Equity losses from unconsolidated joint ventures |
|
(173 |
) |
|
|
(158 |
) |
|
|
(611 |
) |
|
|
(604 |
) |
|
|
|
(3,114 |
) |
|
|
(3,008 |
) |
|
|
(8,357 |
) |
|
|
(26,379 |
) |
|
|
|
|
|
|
|
|
|
||||||||
|
Earnings (loss) before income taxes |
|
(1,376 |
) |
|
|
(5,192 |
) |
|
|
8,707 |
|
|
|
(10,209 |
) |
|
Income tax benefit |
|
(7,332 |
) |
|
|
(6,178 |
) |
|
|
(3,984 |
) |
|
|
(2,422 |
) |
|
Net earnings (loss) |
$ |
5,956 |
|
|
$ |
986 |
|
|
$ |
12,691 |
|
|
$ |
(7,787 |
) |
|
|
|
|
|
|
|
|
|
||||||||
|
Net earnings (loss) per common share - diluted |
$ |
0.19 |
|
|
$ |
0.03 |
|
|
$ |
0.41 |
|
|
$ |
(0.25 |
) |
|
|
|
|
|
|
|
|
|
||||||||
|
Weighted average shares outstanding - diluted |
|
30,768 |
|
|
|
31,766 |
|
|
|
31,279 |
|
|
|
31,887 |
|
|
|
|
|
|
||
|
|
|||||
|
|
|||||
|
Condensed Consolidated Balance Sheets |
|||||
|
(Unaudited) |
|||||
|
(In thousands) |
|||||
|
|
|
|
|
||
|
|
|
|
|
||
|
Assets: |
|
|
|
||
|
|
|
|
|
||
|
Cash and cash equivalents |
$ |
23,448 |
|
$ |
40,841 |
|
Restricted cash |
|
3,134 |
|
|
3,738 |
|
Accounts receivable |
|
19,082 |
|
|
21,457 |
|
Assets held for sale |
|
— |
|
|
1,199 |
|
Other current assets |
|
18,912 |
|
|
24,915 |
|
Property and equipment, net |
|
697,712 |
|
|
685,734 |
|
Operating lease right-of-use assets |
|
142,115 |
|
|
159,194 |
|
Other assets |
|
110,129 |
|
|
107,450 |
|
|
|
|
|
||
|
Total Assets |
$ |
1,014,532 |
|
$ |
1,044,528 |
|
|
|
|
|
||
|
Liabilities and Shareholders' Equity: |
|
|
|
||
|
|
|
|
|
||
|
Accounts payable |
$ |
44,523 |
|
$ |
50,690 |
|
Taxes other than income taxes |
|
18,482 |
|
|
18,696 |
|
Other current liabilities |
|
81,390 |
|
|
78,806 |
|
Current portion of finance lease obligations |
|
2,827 |
|
|
2,591 |
|
Current portion of operating lease obligations |
|
16,219 |
|
|
15,765 |
|
Current maturities of long-term debt |
|
— |
|
|
10,133 |
|
Finance lease obligations |
|
8,452 |
|
|
10,360 |
|
Operating lease obligations |
|
148,977 |
|
|
164,776 |
|
Long-term debt |
|
159,007 |
|
|
149,007 |
|
Deferred income taxes |
|
30,905 |
|
|
32,619 |
|
Other long-term obligations |
|
46,372 |
|
|
46,219 |
|
Equity |
|
457,378 |
|
|
464,866 |
|
|
|
|
|
||
|
Total Liabilities and Shareholders' Equity |
$ |
1,014,532 |
|
$ |
1,044,528 |
|
|
||||||||||||||
|
|
||||||||||||||
|
Business Segment Information |
||||||||||||||
|
(Unaudited) |
||||||||||||||
|
(In thousands) |
||||||||||||||
|
|
Theatres |
|
Hotels/
|
|
Corporate
|
|
Total |
|||||||
|
Three Months Ended |
|
|
|
|
|
|
|
|||||||
|
Revenues |
$ |
123,793 |
|
$ |
69,536 |
|
|
$ |
169 |
|
|
$ |
193,498 |
|
|
Operating income (loss) |
|
7,687 |
|
|
(90 |
) |
|
|
(5,859 |
) |
|
|
1,738 |
|
|
Depreciation and amortization |
|
10,439 |
|
|
7,106 |
|
|
|
370 |
|
|
|
17,915 |
|
|
Adjusted EBITDA |
|
24,112 |
|
|
7,338 |
|
|
|
(4,636 |
) |
|
|
26,814 |
|
|
|
|
|
|
|
|
|
|
|||||||
|
Three Months Ended |
|
|
|
|
|
|
|
|||||||
|
Revenues |
$ |
121,158 |
|
$ |
67,074 |
|
|
$ |
81 |
|
|
$ |
188,313 |
|
|
Operating income (loss) |
|
3,344 |
|
|
481 |
|
|
|
(6,009 |
) |
|
|
(2,184 |
) |
|
Depreciation and amortization |
|
11,452 |
|
|
6,216 |
|
|
|
302 |
|
|
|
17,970 |
|
|
Adjusted EBITDA |
|
23,658 |
|
|
7,095 |
|
|
|
(4,872 |
) |
|
|
25,881 |
|
|
|
|
|
|
|
|
|
|
|||||||
|
Twelve Months Ended |
|
|
|
|
|
|
|
|||||||
|
Revenues |
$ |
462,741 |
|
$ |
295,269 |
|
|
$ |
448 |
|
|
$ |
758,458 |
|
|
Operating income (loss) |
|
29,437 |
|
|
14,416 |
|
|
|
(26,789 |
) |
|
|
17,064 |
|
|
Depreciation and amortization |
|
41,755 |
|
|
26,873 |
|
|
|
1,563 |
|
|
|
70,191 |
|
|
Adjusted EBITDA |
|
76,458 |
|
|
42,719 |
|
|
|
(19,909 |
) |
|
|
99,268 |
|
|
|
|
|
|
|
|
|
|
|||||||
|
Twelve Months Ended |
|
|
|
|
|
|
|
|||||||
|
Revenues |
$ |
447,723 |
|
$ |
287,506 |
|
|
$ |
331 |
|
|
$ |
735,560 |
|
|
Operating income (loss) |
|
22,147 |
|
|
18,477 |
|
|
|
(24,454 |
) |
|
|
16,170 |
|
|
Depreciation and amortization |
|
45,352 |
|
|
21,917 |
|
|
|
689 |
|
|
|
67,958 |
|
|
Adjusted EBITDA |
|
78,070 |
|
|
41,584 |
|
|
|
(17,247 |
) |
|
|
102,407 |
|
|
Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues. |
||||||||||||||
|
|
||||||||||||||||
|
Supplemental Data |
||||||||||||||||
|
(Unaudited) |
||||||||||||||||
|
(In thousands) |
||||||||||||||||
|
|
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
Consolidated |
|
|
|
|
|
|
|
|
||||||||
|
Net cash flow provided by (used in) operating activities |
|
$ |
48,800 |
|
|
$ |
52,566 |
|
|
$ |
84,200 |
|
|
$ |
103,940 |
|
|
Net cash flow provided by (used in) investing activities |
|
|
(24,767 |
) |
|
|
(23,501 |
) |
|
|
(71,373 |
) |
|
|
(81,898 |
) |
|
Net cash flow provided by (used in) financing activities |
|
|
(7,932 |
) |
|
|
(17,531 |
) |
|
|
(30,824 |
) |
|
|
(37,301 |
) |
|
Capital expenditures |
|
|
(22,402 |
) |
|
|
(25,440 |
) |
|
|
(83,211 |
) |
|
|
(79,210 |
) |
|
|
|||||||||||||||
|
|
|||||||||||||||
|
Reconciliation of Net earnings (loss) to Adjusted EBITDA |
|||||||||||||||
|
(Unaudited) |
|||||||||||||||
|
(In thousands) |
|||||||||||||||
|
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Net earnings (loss) |
$ |
5,956 |
|
|
$ |
986 |
|
|
$ |
12,691 |
|
|
$ |
(7,787 |
) |
|
Add (deduct): |
|
|
|
|
|
|
|
||||||||
|
Investment (income) loss |
|
(414 |
) |
|
|
(557 |
) |
|
|
(878 |
) |
|
|
(2,231 |
) |
|
Interest expense |
|
2,903 |
|
|
|
2,812 |
|
|
|
11,472 |
|
|
|
10,972 |
|
|
Other expense (income) (a) |
|
452 |
|
|
|
392 |
|
|
|
(2,848 |
) |
|
|
1,513 |
|
|
(Gain) loss on disposition of property, equipment and other assets |
|
703 |
|
|
|
291 |
|
|
|
(553 |
) |
|
|
386 |
|
|
Equity losses from unconsolidated joint ventures |
|
173 |
|
|
|
158 |
|
|
|
611 |
|
|
|
604 |
|
|
Income tax expense (benefit) |
|
(7,332 |
) |
|
|
(6,178 |
) |
|
|
(3,984 |
) |
|
|
(2,422 |
) |
|
Depreciation and amortization |
|
17,915 |
|
|
|
17,970 |
|
|
|
70,191 |
|
|
|
67,958 |
|
|
Share-based compensation (b) |
|
1,286 |
|
|
|
1,049 |
|
|
|
7,502 |
|
|
|
8,206 |
|
|
Impairment charges (c) |
|
5,172 |
|
|
|
6,351 |
|
|
|
5,172 |
|
|
|
6,823 |
|
|
Theatre exit costs (d) |
|
— |
|
|
|
— |
|
|
|
135 |
|
|
|
136 |
|
|
Insured losses (recoveries) (e) |
|
— |
|
|
|
4 |
|
|
|
(243 |
) |
|
|
243 |
|
|
Debt conversion expense (f) |
|
— |
|
|
|
203 |
|
|
|
— |
|
|
|
15,521 |
|
|
Other non-recurring (g) |
|
— |
|
|
|
2,400 |
|
|
|
— |
|
|
|
2,485 |
|
|
Adjusted EBITDA |
$ |
26,814 |
|
|
$ |
25,881 |
|
|
$ |
99,268 |
|
|
$ |
102,407 |
|
|
Reconciliation of Operating income (loss) to Adjusted EBITDA by Reportable Segment |
||||||||||||||||||||||||||||
|
(Unaudited) |
||||||||||||||||||||||||||||
|
(In thousands) |
||||||||||||||||||||||||||||
|
|
Three Months Ended |
|
Twelve Months Ended |
|||||||||||||||||||||||||
|
|
Theatres |
|
Hotels &
|
|
Corp.
|
|
Total |
|
Theatres |
|
Hotels &
|
|
Corp.
|
|
Total |
|||||||||||||
|
Operating income (loss) |
$ |
7,687 |
|
$ |
(90 |
) |
|
$ |
(5,859 |
) |
|
$ |
1,738 |
|
$ |
29,437 |
|
|
$ |
14,416 |
|
$ |
(26,789 |
) |
|
$ |
17,064 |
|
|
Depreciation and amortization |
|
10,439 |
|
|
7,106 |
|
|
|
370 |
|
|
|
17,915 |
|
|
41,755 |
|
|
|
26,873 |
|
|
1,563 |
|
|
|
70,191 |
|
|
Loss (gain) on disposition of property, equipment and other assets |
|
660 |
|
|
43 |
|
|
|
— |
|
|
|
703 |
|
|
(813 |
) |
|
|
277 |
|
|
(17 |
) |
|
|
(553 |
) |
|
Share-based compensation (b) |
|
154 |
|
|
279 |
|
|
|
853 |
|
|
|
1,286 |
|
|
1,015 |
|
|
|
1,153 |
|
|
5,334 |
|
|
|
7,502 |
|
|
Impairment charges (c) |
|
5,172 |
|
|
— |
|
|
|
— |
|
|
|
5,172 |
|
|
5,172 |
|
|
|
— |
|
|
— |
|
|
|
5,172 |
|
|
Theatre exit costs (d) |
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
135 |
|
|
|
— |
|
|
— |
|
|
|
135 |
|
|
Insured losses (recoveries) (e) |
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
(243 |
) |
|
|
— |
|
|
— |
|
|
|
(243 |
) |
|
Adjusted EBITDA |
$ |
24,112 |
|
$ |
7,338 |
|
|
$ |
(4,636 |
) |
|
$ |
26,814 |
|
$ |
76,458 |
|
|
$ |
42,719 |
|
$ |
(19,909 |
) |
|
$ |
99,268 |
|
|
|
Three Months Ended |
|
Twelve Months Ended |
|||||||||||||||||||||||
|
|
Theatres |
|
Hotels &
|
|
Corp.
|
|
Total |
|
Theatres |
|
Hotels &
|
|
Corp.
|
|
Total |
|||||||||||
|
Operating income (loss) |
$ |
3,344 |
|
$ |
481 |
|
$ |
(6,009 |
) |
|
$ |
(2,184 |
) |
|
$ |
22,147 |
|
$ |
18,477 |
|
$ |
(24,454 |
) |
|
$ |
16,170 |
|
Depreciation and amortization |
|
11,452 |
|
|
6,216 |
|
|
302 |
|
|
|
17,970 |
|
|
|
45,352 |
|
|
21,917 |
|
|
689 |
|
|
|
67,958 |
|
Loss (gain) on disposition of property, equipment and other assets |
|
155 |
|
|
141 |
|
|
(5 |
) |
|
|
291 |
|
|
|
254 |
|
|
137 |
|
|
(5 |
) |
|
|
386 |
|
Share-based compensation (b) |
|
169 |
|
|
257 |
|
|
623 |
|
|
|
1,049 |
|
|
|
932 |
|
|
1,053 |
|
|
6,221 |
|
|
|
8,206 |
|
Impairment charges (c) |
|
6,351 |
|
|
— |
|
|
— |
|
|
|
6,351 |
|
|
|
6,823 |
|
|
— |
|
|
— |
|
|
|
6,823 |
|
Theatre exit costs (d) |
|
— |
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
136 |
|
|
— |
|
|
— |
|
|
|
136 |
|
Insured losses (recoveries) (e) |
|
4 |
|
|
— |
|
|
— |
|
|
|
4 |
|
|
|
243 |
|
|
— |
|
|
— |
|
|
|
243 |
|
Other non-recurring (g) |
|
2,183 |
|
|
— |
|
|
217 |
|
|
|
2,400 |
|
|
|
2,183 |
|
|
— |
|
|
302 |
|
|
|
2,485 |
|
Adjusted EBITDA |
$ |
23,658 |
|
$ |
7,095 |
|
$ |
(4,872 |
) |
|
$ |
25,881 |
|
|
$ |
78,070 |
|
$ |
41,584 |
|
$ |
(17,247 |
) |
|
$ |
102,407 |
|
(a) |
Includes a gain from an insurance settlement of |
|
|
(b) |
Non-cash expense related to share-based compensation programs. |
|
|
(c) |
Non-cash impairment charges in fiscal 2025 related to eight operating theatres and one vacant parcel of land. Non-cash impairment charges in fiscal 2024 related to three operating theatres, one operating theatre that closed in early fiscal 2025, and one permanently closed theatre. Non-cash impairment charges in fiscal 2023 related to one permanently closed theatre. |
|
|
(d) |
Non-recurring costs related to the closure and exit of one theatre location in fiscal 2024. |
|
|
(e) |
Repair costs and insurance recoveries that are non-operating in nature related to insured property damage at one theatre location. |
|
|
(f) |
Debt conversion expense for repurchases of |
|
|
(g) |
Other non-recurring in fiscal 2024 includes settlement and legal expenses related to an equipment lease agreement impacted by the COVID-19 pandemic in Theatres, and professional fees related to convertible debt repurchase transactions and corporate office relocation expenses in Corporate Items. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260225045975/en/
For additional information, contact:
(414) 905-1100
investors@marcuscorp.com
Source: